Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Villain

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
European Journal of Neurology|April 15, 2024
What is Alzheimer's disease? An analysis of nosological perspectives from the 20th and 21st centuriesNicolas Villain, Robin Michalon
Neurology|August 21, 2024
The Great Debate in Diagnosing Alzheimer Disease: More Than Just a β TestNicolas Villain, Melissa S Paretsky
JAMA Neurology|April 21, 2025
IWG and AA Criteria-Where the Differences Matter-ReplyBruno Dubois, Nicolas Villain, Howard H Feldman
IEEE Transactions on Medical Imaging|October 14, 2003
Three-dimensional edge-preserving image enhancement for computed tomographyNicolas Villain, Yves Goussard, Jérôme Idier, et al.
Biologie Aujourd'Hui|October 19, 2010
[Neuroimaging in Alzheimer's disease: a synthesis and a contribution to the understanding of physiopathological mechanisms]Nicolas Villain, Gaël Chételat, Béatrice Desgranges, et al.
Neurology|February 20, 2026
Author Response: The Great Debate in Diagnosing Alzheimer Disease: More Than Just a β TestNicolas Villain, Bernard J Hanseeuw, Vincent Planche, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 17, 2026
Defining Alzheimer's disease: stipulations and the ethics of diagnostic changeRobin Michalon, Vincent Planche, Maël Lemoine, et al.
The Lancet. Neurology|May 23, 2025
The International Working Group recommendations on cognitively unimpaired individualsNicolas Villain, Giovanni B Frisoni, Howard H Feldman, et al.
Psychologie & Neuropsychiatrie Du Vieillissement|December 1, 2007
[Cerebral imaging and physiopathology of Alzheimer's disease]Marine Fouquet, Nicolas Villain, Gaël Chételat, et al.
The Lancet. Neurology|July 19, 2024
Clinical versus biomarker-based diagnosis of neurocognitive disorders - Authors' replyFederico Massa, Nicolas Villain, Matteo Cotta Ramusino, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
European Journal of Neurology|April 15, 2024
What is Alzheimer's disease? An analysis of nosological perspectives from the 20th and 21st centuriesNicolas Villain, Robin Michalon
Neurology|August 21, 2024
The Great Debate in Diagnosing Alzheimer Disease: More Than Just a β TestNicolas Villain, Melissa S Paretsky
JAMA Neurology|April 21, 2025
IWG and AA Criteria-Where the Differences Matter-ReplyBruno Dubois, Nicolas Villain, Howard H Feldman
IEEE Transactions on Medical Imaging|October 14, 2003
Three-dimensional edge-preserving image enhancement for computed tomographyNicolas Villain, Yves Goussard, Jérôme Idier, et al.
Biologie Aujourd'Hui|October 19, 2010
[Neuroimaging in Alzheimer's disease: a synthesis and a contribution to the understanding of physiopathological mechanisms]Nicolas Villain, Gaël Chételat, Béatrice Desgranges, et al.
Neurology|February 20, 2026
Author Response: The Great Debate in Diagnosing Alzheimer Disease: More Than Just a β TestNicolas Villain, Bernard J Hanseeuw, Vincent Planche, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 17, 2026
Defining Alzheimer's disease: stipulations and the ethics of diagnostic changeRobin Michalon, Vincent Planche, Maël Lemoine, et al.
The Lancet. Neurology|May 23, 2025
The International Working Group recommendations on cognitively unimpaired individualsNicolas Villain, Giovanni B Frisoni, Howard H Feldman, et al.
Psychologie & Neuropsychiatrie Du Vieillissement|December 1, 2007
[Cerebral imaging and physiopathology of Alzheimer's disease]Marine Fouquet, Nicolas Villain, Gaël Chételat, et al.
The Lancet. Neurology|July 19, 2024
Clinical versus biomarker-based diagnosis of neurocognitive disorders - Authors' replyFederico Massa, Nicolas Villain, Matteo Cotta Ramusino, et al.
Pageof 8